5Doody, RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology, 2001, 56 (9): 1154-1166.
7Palacios JM. Alzheimer's disease: new pharmacological perspectives [J]. Methods Find Exp Clin Pharmacol, 1996, 18 (Suppl B) : S67-S68.
8Jann, MW. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease [J]. Pharmacotherapy, 2000, 20 (1) : 1-12.
9Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease[J]. Prescrire Int, 2001, 10(56): 180-181.
10Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial[J]. JAm Med Assoc, 2004, 291 (3) : 317-324.
